- Investing Ideas
- Swedish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Swedish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
43
Companies which are more than 50% undervalued based on analyst price target.
43 companies
Bonesupport Holding
Market Cap: SEK 15.0b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEX
SEK 218.60
7D
-2.2%
1Y
-26.1%
Hansa Biopharma
Market Cap: SEK 4.1b
A biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe.
HNSA
SEK 41.74
7D
6.6%
1Y
26.5%
Swedencare
Market Cap: SEK 3.5b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 22.20
7D
3.7%
1Y
-45.6%
Egetis Therapeutics
Market Cap: SEK 3.2b
A pharmaceutical company, engages in the development and commercialization of orphan drugs in Sweden and internationally.
EGTX
SEK 7.33
7D
2.4%
1Y
41.0%
Vicore Pharma Holding
Market Cap: SEK 3.1b
A clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden.
VICO
SEK 11.00
7D
-1.8%
1Y
-0.7%
Saniona
Market Cap: SEK 1.7b
A clinical-stage biopharmaceutical company, focuses on discovering, developing, and delivering innovative treatments for neurological and psychiatric disorders in Ireland, the United States, Germany, Denmark, and the United Kingdom.
SANION
SEK 12.02
7D
-6.7%
1Y
4.0%
BioInvent International
Market Cap: SEK 1.5b
A clinical-stage company, discovers and develops immuno-modulatory antibodies for cancer therapy in Sweden, Europe, the United States, and internationally.
BINV
SEK 24.20
7D
-2.8%
1Y
-36.0%
Cereno Scientific
Market Cap: SEK 1.5b
A clinical stage biotechnology company, develops therapeutics to treat cardiovascular and pulmonary diseases in Sweden.
CRNO B
SEK 4.65
7D
-4.8%
1Y
-50.0%
Genovis AB (publ.)
Market Cap: SEK 1.3b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 20.10
7D
2.6%
1Y
-16.3%
Medivir
Market Cap: SEK 1.1b
A pharmaceutical company, focuses on the development and commercialization of medical treatments in areas of high unmet medical need in Sweden, the Nordic region, the rest of Europe, and internationally.
MVIR
SEK 1.90
7D
14.5%
1Y
-5.0%
SynAct Pharma
Market Cap: SEK 1.1b
A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.
SYNACT
SEK 19.84
7D
-0.5%
1Y
10.6%
Devyser Diagnostics
Market Cap: SEK 1.0b
Provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa.
DVYSR
SEK 59.80
7D
-5.7%
1Y
-59.8%
AlzeCure Pharma
Market Cap: SEK 915.6m
Operates as a pharmaceutical company that develops small-molecule drug therapies for the treatment of severe diseases and conditions that affect the central nervous system.
ALZCUR
SEK 6.42
7D
-4.7%
1Y
66.8%
Cinclus Pharma Holding
Market Cap: SEK 609.6m
A clinical-stage pharmaceutical company, develops small molecules for the treatment of gastric acid-related diseases in China.
CINPHA
SEK 13.20
7D
11.7%
1Y
-17.8%
Moberg Pharma
Market Cap: SEK 534.1m
A pharmaceutical company, develops and commercializes medical products primarily in Sweden.
MOB
SEK 10.62
7D
-4.2%
1Y
29.4%
FluoGuide
Market Cap: SEK 526.4m
A clinical stage biotechnology company, develops drugs for precision cancer surgery in Denmark.
FLUO
SEK 31.70
7D
-3.9%
1Y
-21.3%
Xspray Pharma
Market Cap: SEK 493.1m
A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.
XSPRAY
SEK 10.46
7D
-23.6%
1Y
-75.5%
Orexo
Market Cap: SEK 489.6m
A pharmaceutical company, provides advance treatments for severe diseases and life-saving rescue medications in the United States, European Union, the United Kingdom, and internationally.
ORX
SEK 13.86
7D
-8.8%
1Y
-33.4%
Corline Biomedical
Market Cap: SEK 470.4m
Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications in Sweden.
CLBIO
SEK 18.15
7D
0.3%
1Y
45.8%
Cantargia
Market Cap: SEK 459.9m
A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.
CANTA
SEK 2.09
7D
15.1%
1Y
-19.2%
Mendus
Market Cap: SEK 427.0m
A biopharmaceutical company, develops immunotherapies for the treatment of myeloid blood cancers.
IMMU
SEK 6.85
7D
-0.7%
1Y
-7.6%
Intervacc
Market Cap: SEK 376.3m
Develops novel veterinary vaccines for animals in Sweden.
IVACC
SEK 1.09
7D
-9.3%
1Y
2.3%
Sprint Bioscience
Market Cap: SEK 317.6m
A pharmaceutical company, engages in the development of drug candidates to treat cancer in Sweden.
SPRINT
SEK 3.17
7D
-4.8%
1Y
423.1%
Isofol Medical
Market Cap: SEK 256.4m
Operates as a clinical stage biotech company.
ISOFOL
SEK 0.82
7D
-3.5%
1Y
-5.0%
IRLAB Therapeutics
Market Cap: SEK 255.2m
IRLAB Therapeutics AB (publ) discovers and develops drugs for the treatment of Parkinson’s disease and other central nervous system (CNS) disorders in the United States.
IRLAB A
SEK 1.72
7D
4.2%
1Y
-43.9%
Xbrane Biopharma
Market Cap: SEK 197.0m
A biotechnology company, engages in the development, manufacture, and sale of biosimilars.
XBRANE
SEK 9.50
7D
-2.5%
1Y
-73.4%
Elicera Therapeutics
Market Cap: SEK 173.5m
A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.
ELIC
SEK 2.59
7D
-9.8%
1Y
-56.9%
Initiator Pharma
Market Cap: SEK 173.2m
A clinical-stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous systems.
INIT
SEK 2.59
7D
4.9%
1Y
-28.1%
Alzinova
Market Cap: SEK 166.0m
A clinical-stage biopharma company, develops immunotherapies treatment for Alzheimer’s disease in Sweden.
ALZ
SEK 0.82
7D
-16.0%
1Y
-43.0%
KDventures
Market Cap: SEK 153.9m
A venture capital firm specializing in investments in growth capital, seed stage, and early stage companies.
KDV B
SEK 0.24
7D
-3.3%
1Y
-76.4%
Nanologica
Market Cap: SEK 147.3m
A life science tools company, develops, manufactures, and sells nanoporous silica particles in China, India, Turkey, the United States, and internationally.
NICA
SEK 0.44
7D
-5.1%
1Y
-70.0%
Active Biotech
Market Cap: SEK 139.7m
A biotechnology company, engages in the research, development, production, marketing, and sale of medical, chemical, and biotechnology products in Sweden.
ACTI
SEK 5.30
7D
2.1%
1Y
-69.4%
NextCell Pharma
Market Cap: SEK 139.0m
A biopharmaceutical company, engages in the research, development, and manufacture of stromal cell therapies in Sweden.
NXTCL
SEK 1.18
7D
16.6%
1Y
3.0%
Vivesto
Market Cap: SEK 98.1m
Develops, develops, markets, and sells drugs in the field of human and veterinary oncology in Sweden.
VIVE
SEK 8.82
7D
-1.8%
1Y
-63.2%
IDL Diagnostics
Market Cap: SEK 94.4m
A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.
IDLDX
SEK 0.41
7D
9.3%
1Y
-12.9%
Annexin Pharmaceuticals
Market Cap: SEK 90.4m
A clinical stage biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases.
ANNX
SEK 13.20
7D
5.2%
1Y
-54.2%